Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

Do Targeted Therapies Drive Disparities?

Sunday, April 28, 2019

After the implementation of targeted therapies, researchers saw a larger gap in breast cancer mortality rates between African American and Caucasian women, according to Melissa B. Davis, PhD, an assistant professor at Weill Cornell Medicine. 

Targeted therapies caused a decline in deaths in white women, while deaths in black women essentially stayed the same. Some of this can be attributed to access to healthcare, but upon further investigation, researchers also found that the 2 groups have differences in their tumor biology and types of breast cancer, thus making these new treatments more efficacious in the Caucasian population.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.